Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors.
Yamasaki S, Henzan H, Ohno Y, Yamanaka T, Iino T, Itou Y, Kuroiwa M, Maeda M, Kawano N, Kinukawa N, Miyamoto T, Nagafuji K, Shimoda K, Inaba S, Hayashi S, Taniguchi S, Shibuya T, Gondo H, Otsuka T, Harada M; Fukuoka Blood and Marrow Transplantation Group. Yamasaki S, et al. Among authors: otsuka t. Bone Marrow Transplant. 2003 Sep;32(5):505-10. doi: 10.1038/sj.bmt.1704165. Bone Marrow Transplant. 2003. PMID: 12942097
A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.
Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, Henzan H, Himeji D, Koyama T, Miyake K, Inoue Y, Nakashima H, Otsuka T, Tanaka Y, Nagasawa K, Harada M. Tsukamoto H, et al. Among authors: otsuka t. Ann Rheum Dis. 2006 Apr;65(4):508-14. doi: 10.1136/ard.2005.037879. Epub 2005 Aug 26. Ann Rheum Dis. 2006. PMID: 16126798 Free PMC article. Clinical Trial.
Intracellular cytokine profile of CD14 positive cells in patients with hematologic malignancies and solid tumors during hematologic recovery phase after intensive chemotherapy designed to mobilize peripheral blood stem cells.
Maeda M, Tokunaga Y, Nomura A, Inaba S, Sugio Y, Itoh Y, Iino T, Otsuka T, Niho Y. Maeda M, et al. Among authors: otsuka t. Biomed Pharmacother. 2001 Mar;55(2):96-101. doi: 10.1016/s0753-3322(00)00022-6. Biomed Pharmacother. 2001. PMID: 11293819 Clinical Trial.
1,844 results